AUSTRALIAN joint venture cannabis company MedReleaf has announced its entry into the local market, having been granted 'cultivation and production' and 'import' licenses by the Federal Office of Drug Control.
The company is now taking early orders from pharmacies and hospitals, with product to be initially imported from Canada.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Feb 18
